Amneal Pharmaceuticals - M&A Summary and Business Overview

Healthcare ServicesCompany

Amneal Pharmaceuticals M&A Summary

Amneal Pharmaceuticals has acquired 6 companies, including 3 in the last 5 years. A total of 1 acquisition came from private equity firms. It has also divested 2 assets.

Amneal Pharmaceuticals’ largest acquisition to date was in 2019, when it acquired AvKARE for $340M. Amneal Pharmaceuticals has acquired in 5 different US states. The Company’s most targeted sectors include life science (84%) and medical products (17%).

Amneal Pharmaceuticals Business Overview

Where is Amneal Pharmaceuticals headquartered?

Amneal Pharmaceuticals is headquartered in Bridgewater, New Jersey.

What is Amneal Pharmaceuticals’ revenue?

Amneal Pharmaceuticals disclosed revenue of 2,394M USD for 2023 and 2,212M USD for 2022.

How many employees does Amneal Pharmaceuticals have?

Amneal Pharmaceuticals has 7,850 employees.

What sector is Amneal Pharmaceuticals in?

Amneal Pharmaceuticals is a healthcare services company.

When was Amneal Pharmaceuticals founded?

Amneal Pharmaceuticals was founded in 2002.

M&A Summary

  • M&A Total Activity8
    • M&A Buy Activity6
    • M&A Sell Activity2
  • Total Sectors Invested 2
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 4
  • M&A Advisors 6

Amneal Pharmaceuticals

Amneal Pharmaceuticals, Inc.

400 Crossing Boulevard 3rd Floor,
Bridgewater, New Jersey 08807
United States,
(908) 947-3120
www.amneal.com

Amneal Pharmaceuticals manufactures and supplies generic pharmaceuticals. The company offers prescription pharmaceutical products in various forms, including oral solids that range from tablets to capsules and soft gels; and liquid-form pharmaceuticals that range from suspensions to solutions. Amneal Pharmaceuticals was incorporated in 2002 and is based in Bridgewater, New Jersey.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.4/yr) # 4 - 1 1 - - 6
vol $340M $340M
Sell (0.0/yr) # 2 - - - - - 2
  8

Most Recent M&A

Company Date Value Type
Saol Therapeutics - Baclofen Franchise 2022-01-05 - Divestiture
Roswell, Georgia
Kashiv Specialty Pharmaceuticals LLC 2021-04-05 - Divestiture
Piscataway, New Jersey · www.kashivsp.com
AvKARE, Inc. 2019-12-10 340M USD Add-on Acquisition
Pulaski, Tennessee · www.avkare.com
Amneal Deutschland GmbH 2019-05-17 - Divestiture
Gröbenzell, Germany · www.amneal.de
Gemini Laboratories LLC 2018-05-07 - Add-on Acquisition
Bridgewater, New Jersey · www.gemini-labs.com
Impax Laboratories, Inc. 2018-05-07 - Merger
Hayward, California · www.impaxlabs.com
Amneal Pharmaceuticals LLC - Generic Products and Assets 2018-04-27 - Divestiture
Bridgewater, New Jersey
Interpharm Holdings, Inc. 2008-06-01 - Add-on Acquisition
Hauppauge, New York
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 5 (83%) - 2 (100%) -
Medical Products 1 (17%) 340M (100%) - -
Total 6 $340M 2 -

By Geo

State/Country Buy Value Sell Value
United States 6 340M 1 -
  New Jersey 2 - 1 -
  Tennessee 1 340M - -
  New York 1 - - -
  Georgia 1 - - -
  California 1 - - -
Germany - - 1 -
Domestic 6 (100%) 340M (100%) 1 (50%) -
Cross-border - - 1 (50%) -
Total 6 $340M 2 -

Top M&A Advisors

Financial Deals
BofA Securities
1
J.P. Morgan Securities
1
RBC Capital Markets
1
Legal Deals
Latham & Watkins
1
Morgan Lewis
1

Deal Values

buy # Total
$100M to $1B 1 $340M
TOTAL $340M
Largest AvKARE, Inc.
$340M (2019-12-10)

M&A Connections

Deals
Acquired from
Investor(s)
17%
1 (17%)
Strategic(s)
17%
1 (17%)
Divested to
Strategic(s)
100%
2 (100%)

 Subscribe to unlock this and 209,180
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.